Glucose tolerance in HIV-1 treated patients who switched from boosted-protease inhibitors to etravirine

AIDS. 2013 Oct 23;27(16):2661-3. doi: 10.1097/01.aids.0000432464.31132.86.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Anti-HIV Agents / adverse effects
  • Anti-HIV Agents / therapeutic use*
  • Glucose Tolerance Test
  • HIV Infections / drug therapy*
  • HIV Infections / virology
  • HIV-1 / isolation & purification
  • Humans
  • Male
  • Middle Aged
  • Nitriles
  • Prospective Studies
  • Protease Inhibitors / adverse effects
  • Protease Inhibitors / therapeutic use*
  • Pyridazines / adverse effects
  • Pyridazines / therapeutic use*
  • Pyrimidines

Substances

  • Anti-HIV Agents
  • Nitriles
  • Protease Inhibitors
  • Pyridazines
  • Pyrimidines
  • etravirine